Researchers from the University of Oxford have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.
Oesophageal cancer: the global clinical trials landscape in 2024 – Pharmaceutical Technology
Illustration showing malignant tumor in the human oesophagus. Credit: Shutterstock Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer